The aim of the invention is to extend a range of antiviral drugs by using
entovirons in the form of components of an insect hemolymph exhibiting a
direct antiviral action. The entovirons obtainable from Odonata,
Coleoptera, Lepidoptera and Diptera representatives are most efficient in
the form of drug prototypes.